日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient centered HCC surveillance - complementary roles of ultrasound and CT/MRI

以患者为中心的肝细胞癌监测——超声和CT/MRI的互补作用

Heald, Jason; Fetzer, David T; Rodgers, Shuchi; Jain, Vaibhav; Fung, Alice; Liu, Xiaoyang; Wilson, Stephanie; Kamaya, Aya; Marks, Robert M

Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia

针对人类急性髓系白血病的C型凝集素样分子-1嵌合抗原受体的开发

Eduardo Laborda, Magdalena Mazagova, Sida Shao, Xinxin Wang, Herlinda Quirino, Ashley K Woods, Eric N Hampton, David T Rodgers, Chan Hyuk Kim, Peter G Schultz, Travis S Young3

Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate

通过抗体-药物偶联物将抗炎PDE4抑制剂靶向递送至免疫细胞

Shan Yu ,Aaron D Pearson ,Reyna Kv Lim ,David T Rodgers ,Sijia Li ,Holly B Parker ,Meredith Weglarz ,Eric N Hampton ,Michael J Bollong ,Jiayin Shen ,Claudio Zambaldo ,Danling Wang ,Ashley K Woods ,Timothy M Wright ,Peter G Schultz ,Stephanie A Kazane ,Travis S Young ,Matthew S Tremblay

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ

蠕虫产品 ES-62 通过诱导 TLR 传感器的选择性自噬溶酶体降解来调节树突状细胞反应,例如 PKCδ

Russell J Eason, Kara S Bell, Fraser A Marshall, David T Rodgers, Miguel A Pineda, Christina N Steiger, Lamyaa Al-Riyami, William Harnett, Margaret M Harnett

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

针对 B 细胞恶性肿瘤的 CAR-T 细胞开关介导激活和重新靶向

David T Rodgers, Magdalena Mazagova, Eric N Hampton, Yu Cao, Nitya S Ramadoss, Ian R Hardy, Andrew Schulman, Juanjuan Du, Feng Wang, Oded Singer, Jennifer Ma, Vanessa Nunez, Jiayin Shen, Ashley K Woods, Timothy M Wright, Peter G Schultz, Chan Hyuk Kim, Travis S Young

Versatile strategy for controlling the specificity and activity of engineered T cells

控制工程 T 细胞特异性和活性的多功能策略

Jennifer S Y Ma, Ji Young Kim, Stephanie A Kazane, Sei-Hyun Choi, Hwa Young Yun, Min Soo Kim, David T Rodgers, Holly M Pugh, Oded Singer, Sophie B Sun, Bryan R Fonslow, James N Kochenderfer, Timothy M Wright, Peter G Schultz, Travis S Young, Chan Hyuk Kim, Yu Cao

The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice

寄生虫产品 ES-62 靶向髓系分化因子 88 依赖性效应机制,以抑制 MRL/lpr 小鼠的抗核抗体产生和蛋白尿

David T Rodgers, Mairi A McGrath, Miguel A Pineda, Lamyaa Al-Riyami, Justyna Rzepecka, Felicity Lumb, William Harnett, Margaret M Harnett

ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints

ES-62 通过重置白细胞介素-22,使其向关节炎症消退的方向发展,从而起到预防胶原蛋白诱导性关节炎的作用。

Miguel A Pineda ,David T Rodgers, Lamyaa Al-Riyami, William Harnett, Margaret M Harnett

Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis

从寄生虫中设计抗炎药物:棘唇虫产品 ES-62 的合成小分子类似物可防止胶原诱导性关节炎的发展

Lamyaa Al-Riyami, Miguel A Pineda, Justyna Rzepecka, Judith K Huggan, Abedawn I Khalaf, Colin J Suckling, Fraser J Scott, David T Rodgers, Margaret M Harnett, William Harnett